Tasosartan and hydroclorothiazide as combination therapy in the treatment of severe essential hypertension: comparison with enalapril. Tasosartan Study Group.
Viigimaa
M
M
Allikmets
K
K
Parik
T
T
Skards
J
J
Franken
A
A
Häss
G
G
D000704:Analysis of Variance; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D004311:Double-Blind Method; D004338:Drug Combinations; D004656:Enalapril / Q000627:therapeutic use*; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D008875:Middle Aged; D011743:Pyrimidines / Q000627:therapeutic use*; D013777:Tetrazoles / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D004338:Drug Combinations; D011743:Pyrimidines; D013777:Tetrazoles; D006852:Hydrochlorothiazide; D000804:Angiotensin II; C086167:tasosartan; D004656:Enalapril